Comparing Survival Outcomes of Patients With LI‐RADS‐M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.28218
Abstract: There is a sparsity of data evaluating outcomes of patients with Liver Imaging Reporting and Data System (LI‐RADS) (LR)‐M lesions. read more here.
Keywords: outcomes patients; comparing survival; rads hepatocellular; hepatocellular carcinomas ... See more keywords
Small hepatocellular carcinomas displayed as a ring enhancing mass on arterial phase MRI in the chronically diseased liver.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical radiology"
DOI: 10.1016/j.crad.2017.07.001
Abstract: AIM To assess the prevalence of arterial phase (AP) ring-enhancing small hepatocellular carcinomas (HCC) on magnetic resonance imaging (MRI); detail additional MRI features that enable HCC diagnosis; and examine arterial timing as one possible cause… read more here.
Keywords: arterial phase; small hepatocellular; hepatocellular carcinomas; mri ... See more keywords
Hepatocellular Carcinomas can be SATB2 positive: An Important Diagnostic Pitfall.
Sign Up to like & getrecommendations! Published in 2020 at "Human pathology"
DOI: 10.1016/j.humpath.2020.09.001
Abstract: SATB2 is a sensitive and specific marker for tumors originating with the colon and appendix. It is now commonly used in surgical pathology, while working up carcinomas of unknown primary. We had anecdotally encountered occasional… read more here.
Keywords: satb2 positive; pathology; hepatocellular carcinomas; satb2 expression ... See more keywords
Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
Sign Up to like & getrecommendations! Published in 2019 at "Pathology"
DOI: 10.1016/j.pathol.2019.06.001
Abstract: Development, course of disease and prognosis of hepatocellular carcinomas (HCC) are strongly influenced by the immune system. Immunosuppressive regulatory T cells (Treg) have been shown to negatively impact disease progression and survival. To further understand… read more here.
Keywords: ccl1; tissue; hepatocellular carcinomas; ccl1 ccl22 ... See more keywords
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.
Sign Up to like & getrecommendations! Published in 2018 at "Genome research"
DOI: 10.1101/gr.230219.117
Abstract: Cisplatin reacts with DNA and thereby likely generates a characteristic pattern of somatic mutations, called a mutational signature. Despite widespread use of cisplatin in cancer treatment and its role in contributing to secondary malignancies, its… read more here.
Keywords: secondary malignancies; cisplatin; hepatocellular carcinomas; cisplatin mutational ... See more keywords
Erratum to: Imaging findings of fibrolamellar hepatocellular carcinomas on ultrasonography: A comparison with conventional hepatocellular carcinomas.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical hemorheology and microcirculation"
DOI: 10.3233/ch-219901
Abstract: Tiantian Fua, Hong Dingb,∗, Chen Xuc, Yuli Zhua, Liyun Xuea and Feng Lind,∗ aDepartment of Ultrasound, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China bDepartment of Ultrasound, Huashan Hospital, Fudan University, Shanghai,… read more here.
Keywords: fudan university; hepatocellular carcinomas; hospital fudan; carcinomas ... See more keywords
Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10102361
Abstract: The guidelines recommend radiofrequency ablation (RFA) for early hepatocellular carcinomas that are less than 3 cm and trans-arterial chemoembolization (TACE) for intermediate-stage tumors. Real-world patient and tumor factors commonly limit strict adherence to the guidelines.… read more here.
Keywords: early hepatocellular; hepatocellular carcinomas; tace; ablation ... See more keywords
Clinical Characteristics of TZAP (ZBTB48) in Hepatocellular Carcinomas from Tissue, Cell Line, and TCGA
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58121778
Abstract: Background and Objectives: ZBTB48 is a telomere-related protein that has been renamed telomeric zinc finger-associated protein (TZAP). It favorably binds to elongated telomeres to regulate their appropriate length. However, TZAP expression has not been investigated… read more here.
Keywords: tzap expression; hepatocellular carcinomas; cell line; hcc ... See more keywords